DMEK Endothelial Keratoplasty in Patients With a History of Anterior or Posterior Segment Surgery
NCT06013462 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2025-12-08
Summary
DMEK (Descemet Membrane Endothelial Keratoplasty) is a surgical technique used to treat primary or secondary corneal endothelial decompensation. At the Rothschild Foundation, as in many Western referral centers, DMEK is currently the surgical technique of choice for the treatment of primary or secondary corneal endothelial decompensation.
Technically challenging, it is a relatively tedious surgery to learn, but offers the best visual and refractive results, as well as faster visual and functional recovery in simple cases.
In patients without anterior or posterior segment surgical history, the complication rate of DMEK, including graft rejection, is similar to that of other endothelial keratoplasty surgical techniques.
However, in specific cases, in patients with a history of ophthalmological surgery such as vitrectomy, trabeculectomy, large iris defects, anterior synechiae, aniridia or aphakia, the scientific literature shows a higher complication rate for DMEK (increased rate of rebulling and graft decompensation).
As a result, other techniques that are less effective on visual results continue to be used for these patients in a large number of centers.
Nonetheless, in our department, DMEK is also performed on these complicated patients.
When it comes to patients with a history of anterior or posterior segment surgery, it seems to us that the surgeons' experience with DMEK allows better visual results than with any other technique, but without any back up regarding the complication rate in the literature.
The main aim of this study is to describe, in patients with a history of anterior or posterior segment surgery undergoing DMEK, the 12-months occurrence rate of at least one serious post-operative complication.
Conditions
- Patients Undergoing DMEK With a History of Anterior or Posterior Segment Surgery
Interventions
- PROCEDURE
-
Descemet Membrane Endothelial Keratoplasty
DMEK (Descemet Membrane Endothelial Keratoplasty) is a surgical technique used to treat primary or secondary corneal endothelial decompensation.
Sponsors & Collaborators
-
Fondation Ophtalmologique Adolphe de Rothschild
lead NETWORK
Principal Investigators
-
Alain SAAD · Fondation Ophtalmologique A. de Rothschild
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-15
- Primary Completion
- 2027-03-14
- Completion
- 2028-04-30
Countries
- France
Study Locations
More Related Trials
-
Evaluation of a New Surgical Technique for Macular Hole Which Was Not Closed After a Previous Surgery
NCT02946372 ·Status: TERMINATED ·Phase: NA
-
Comparative Results After DSAEK, UT-DSAEK and DMEK for Fuchs Endothelial Corneal Dystophy
NCT04424550 ·Status: COMPLETED
-
"Cataract Surgery in Eyes With Epiretinal Membrane"
NCT03404323 ·Status: COMPLETED
-
Vitrectomy With Planned Foveal Detachment for Refractory DME With or Without Vitreo-macular Interface Abnormality
NCT03345056 ·Status: UNKNOWN ·Phase: NA
-
Effect of the Membrane Blue Dual® Dye on the Retinal Sensitivity in Macular Hole Surgery
NCT02894424 ·Status: COMPLETED
-
Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery
NCT03045367 ·Status: COMPLETED
-
ILM Peeling in PDR Patients Undergoing PPV for VH
NCT03660371 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Myopic Macular Hole Closure Surgery Without Endotamponade Agent
NCT07129798 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo)
NCT04337944 ·Status: UNKNOWN ·Phase: NA
-
Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy
NCT06343961 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Intravitreal Topotecan for Prevention or Treatment of Proliferative Vitreoretinopathy in Retinal Detachment
NCT06818721 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD
NCT00401713 ·Status: COMPLETED ·Phase: NA
-
Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes
NCT00302328 ·Status: COMPLETED ·Phase: NA
-
Evaluating Medium-chain Triglycerides as a Temporary Intraocular Tamponading Agent for Retinal Detachment
NCT03855462 ·Status: COMPLETED ·Phase: NA
-
Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery.
NCT01959568 ·Status: UNKNOWN ·Phase: NA
-
Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty
NCT05399095 ·Status: COMPLETED ·Phase: NA
-
Effect on the Vitreous of the Not Complicated Surgery of the Cataract to the Emmetropic Patient
NCT02783209 ·Status: TERMINATED ·Phase: NA
-
Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment
NCT03618498 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy
NCT05523869 ·Status: RECRUITING ·Phase: PHASE2
-
Macular Micro Vascular Changes Following Macular Hole Repair : Optical Coherence Tomography Angiography Study
NCT06233500 ·Status: RECRUITING ·Phase: NA
-
Transconjunctival Sutureless 25-Gauge Vitrectomy
NCT00870597 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Intravitreal Glucose in Macular Thinning Following Surgery for Retinal Detachment or Epimacular Membrane
NCT02210481 ·Status: COMPLETED
-
Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
NCT00407108 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of Visual Functions After Pars Plana Vitrectomy With and Without Internal Limiting Membrane Peeling in RRD
NCT04139811 ·Status: COMPLETED ·Phase: NA
-
Combined Versus Successive Macular Hole and Cataract Surgery
NCT01069029 ·Status: COMPLETED